Separation and identification of purine nucleosides in the urine of patients with malignant cancer by reverse phase liquid chromatography/ electrospray tandem mass spectrometry

Journal of Mass Spectrometry

Volumn 44, Issue 5, 2009, Pages 641-651

  Li, Hua Yu ^a   Wang, Shao Min ^a   Liu, Hong Min ^a   Bu, Shan Shan ^a   Li, Juan ^b   Han, Dong ^a   Zhang, Ming Zhi ^c   Wu, Guang Yin ^c  

^a ZHENGZHOU UNIVERSITY   (China)

^b HEBEI NORMAL UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Cancer patients; HPLC ESI MS; Purine nucleosides; Q TOFMS; Urine

Indexed keywords

CANCER PATIENTS; HPLC/ESI-MS; PURINE NUCLEOSIDES; Q-TOFMS; URINE;

BODY FLUIDS; CHROMATOGRAPHIC ANALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; LIQUIDS; MASS SPECTROMETERS; MASS SPECTROMETRY; SPECTRUM ANALYSIS;

BIOMOLECULES;

5' METHYLTHIOADENOSINE; 7 METHYLGUANINE; ADENOSINE; ADENOSINE DERIVATIVE; GUANOSINE; INOSINE; PURINE NUCLEOSIDE DERIVATIVE; XANTHINE;

ARTICLE; CANCER PATIENT; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LYMPHOMA; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TANDEM MASS SPECTROMETRY; URINALYSIS; URINE;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; LYMPHOMA; PURINE NUCLEOSIDES; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 66349088527     PISSN: 10765174     EISSN: 10969888     Source Type: Journal    
DOI: 10.1002/jms.1539     Document Type: Article

References (33)

1. C. W. Gehrke, K. C. Kuo, T. P. Waalkes, E. Borek. Patterns of urinary excretion ofmodified nucleosides. Cancer Research 1979, 39, 1150.
2. C.W.Gehrke, K. C. Kuo, G. E. Davies, R.D.Suits, T.P.Waalkes, E. Borek. Quantitative high-performance liquid chromatography of nucleosides in biological materials. Journal of Chromatography 1978, 750, 455.
3. E. Borek, T. P. Waalkes, C. W. Gehrke. Tumor markers derived from nucleic acid components. Cancer Detection and Prevention 1983, 6, 67.
4. K. Nakano, T. Nakao, K. H. Schram, W. M. Hammargren. Estimation of whole-body RNA catabolism based on the urinary modified nucleoside levels of cancer and AIDS patients. Nucleic Acids Symposium Series 1991, 25, 125.
5. J.Thomale, A. Luz, G. Nass. Excretion ofmodified nucleosides during development of malignant lymphomas in mice after whole body irradiation. Journal of Cancer Research and Clinical Oncology 1984, 708, 302.
6. H.M.Liebich, R. Lehmann, G.Xu, H.G.Wahl, H.-U.Haring. Application of capillary electrophoresis in clinical chemistry: the clinical value of urinary modified nucleosides. Journal of Chromatography B 2000, 745, 189.
7. A.J.Sasco, F.Rey, C.Reynaud, J.Y.Bobin, M.Clavel, A.Niveleau. Breast cancer prognostic significance of some modified urinary nucleosides. Cancer Letters 1996 108, 157.
8. H. M. Liebich, S. Mueller-Hagedorn, F. Klaus, K. Meziane, K.-R. Kim, A. Frickenschmidt, B. Kammerer. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers. Journal of Chromatography A 2005 1071, 271.
9. J.I.Langridge, T.D.McClure, S.Sharkawi, A.Fielding, K.H.Schram, R. P. Newton. Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers. Rapid Communications in Mass Spectrometry 1993, 7, 427.
10. R. E. March. An introduction to quadrupole ion trap mass spectrometry. Journal of Mass Spectrometry 1997, 32, 351.
11. A.G.Marshall, C. L. Hendrickson, G.S.Jackson. Fourier transform ion cyclotron resonance mass spectrometry: a primer. Mass Spectrometry Reviews 1998 17, 1.
12. F.W.Crow, K.B.Tomer, M.L.Gross, J. A. McCloskey, D. E. Berstrom. Fast atom bombardment combined with tandem mass spectrometry for the determination of nucleosides. Analytical Biochemistry 1984 139, 243.
13. S. S. Jensen, X. Ariza, P. Nielsen, J. Vilarrasa, F. Kirpekar. Collosion-induced dissociation of cytidine and its derivatives. Journal of Mass Spectrometry 2007, 42, 49.
14. A. M. Kamel, B. Munson. Collisionally-induced dissociation of substituted pyrimidine antiviral agents: mechanisms of ion formation using gas phase hydrogen/deuterium exchange and electrospry ionization tandem mass spectrometry. Journal of the American Society for Mass Spectrometry 2007 18, 1477.
15. C. C. Nelson, J. A. McCloskey. Collision-induced dissociation of adenine. Journal of the American Chemical Society 1992114, 3661.
16. D. Bullinger, A. Frickenschmidt, M. Pelzing, G. Zurek, S. Laufer, T. Zey, B. Kammerer. Identification of urinary nucleosides by ESI- TOF-MS. LC-GC Europe, December 2005, pp2.
17. M. Pelzing, M.Macht. The Applications Book: Determination of Elemental Composition of Phytohormones using LC-ESI-TOF MS for Accurate Mass Measerements, Bruker Daltonik Gmbh: Germany, 2004, 24.
18. I. V. Chernushevich, A. V. Loboda, B. A. Thomson. An introduction to quadrupole time-of-flight mass Spectrometry. Journal of Mass Spectrometry 2001, 36, 849.
19. P. A. Limbach, P. F.Crain, J. A. McCloskey. Summary: The modified nucleosides of RNA. Nucleic Acids Research 1994, 22, 2183.
20. K. H. Schram. Urinary nucleosides. Mass Spectrometry Reviews 1998, 17, 131.
21. R. Bredy, J. Bernard, L. Chen, M.C.Buchet-Poulizac, S.Martin. Dissociation of charge selected biomolecules induced by electronic capture processes in collisions woth positive ions. Nuclear Instruments and Methods in Physical Research Section B 2007, 261, 114.
22. F. Turecek, X. H. Chen. Protonated adenine: tautomers, solvated clusters, and dissociation mechanisms. Journal of the American Chemical Society 2005 16, 1713.
23. B. Kammerer, A. Frickenschmidt, C. H. Gleiter. MALDI-TOF MS analysis of urinary nucleosides. Journal of the American Society for Mass Spectrometry 2005 16, 940.
24. B. Kammerer, A. Frickenschmidt, C. E. Muller, S. Laufer, C. H. Gleiter, H. M. Liebich. Mass spectrometric identification of modified urinary nucleosides used as potential biomedical markers by LC-ITMS coupling. Analytical and Bioanalytical Chemistry 2005, 382, 1017.25.
25. E.Dudley, F. Lèmiere, W. Van Dongen, R. Tuytten, S. El-Sharkawi, A. G. Brenton1, E. L. Esmans, R. P. Newton. Analysis of urinary nucleosides. IV. Identification of urinary purine nucleosides by liquid chromatography/ electrospray mass spectrometry. Rapid Communications in Mass Spectrometry 2004 18, 2730.
26. H.Y.Li, S.M.Wang, H.M.Liu, J.Li, D.Han, S. S. Bu, M.Z.Zhang. Analysis of modified nucleosides in the urine of patients with malignant cancer by liquid chromatography/electrospray mass spectrometry. Rapid Communications in Mass Spectrometry 2008, 22, 3161.
27. O. Curcuruto, G. Tarzia, M. Hamdan. Differentiation between isomeric methylated purine derivatives by means of chemical ionization and collision-induced dissociation. Rapid Communications in Mass Spectrometry 1992, 6, 596.
28. B. Kralj, D. Zigon, D. Kocjan, J.Kobe. Metastable and collision-activated decomposition of protonated molecules of isomeric N7- and N9- substituted purines in the gas phase. Rapid Communications in Mass Spectrometry 199711, 273.
29. B. D. Nourse, R. L. Hettich, M. V. Buchanan. Methyl guanine isomer distinction by hydrogen/deuterium exchange using a fourier- transform mass spectrometer. Journal of the American Society for Mass Spectrometry 1993, 4, 296.
30. B. Tuytten, F. Lemière, E. L. Esmans, W.A.Herrebout, B.J.van der Veken, E. Dudley, R. P. Newton, E. Witters. In-Source CID of guanosine: gas phase ion-molecule reactions. Journal of the American Society for Mass Spectrometry 2006 17, 1050.
31. J. M. Gregson, J. A. McCloskey. Collision-induced dissociation of protonated guanine. International Journal of Mass Spectrometry and Ion Processes 1997 65/166, 475.
32. P.Frycak, R.Huskova, T.Adam, K.Lemr.Atmosphericpressure ionization mass spectrometry of purine and pyrimidine markers of inherited metabolic disorders. Journal of Mass Spectrometry 2002, 37, 1242.
33. 6-methyl-guanine lesions. Biochemistry 2006, 103, 10701.